Cargando…
Correction to Novel Thienopyrimidine-Based PET Tracers for P2Y(12) Receptor Imaging in the Brain
Autores principales: | van der Wildt, Berend, Janssen, Bieneke, Pekošak, Aleksandra, Stéen, E. Johanna L., Schuit, Robert C., Kooijman, Esther J. M., Beaino, Wissam, Vugts, Danielle J., Windhorst, Albert D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9060419/ https://www.ncbi.nlm.nih.gov/pubmed/35191680 http://dx.doi.org/10.1021/acschemneuro.2c00110 |
Ejemplares similares
-
Novel Thienopyrimidine-Based PET Tracers for P2Y(12) Receptor Imaging in the Brain
por: van der Wildt, Berend, et al.
Publicado: (2021) -
Towards PET imaging of the dynamic phenotypes of microglia
por: Beaino, Wissam, et al.
Publicado: (2021) -
Synthesis and Preclinical Evaluation of the First
Carbon-11 Labeled PET Tracers Targeting Substance P(1–7)
por: Pekošak, Aleksandra, et al.
Publicado: (2018) -
Synthesis and
Preclinical Evaluation of [Methylpiperazine-(11)C]brigatinib as a PET Tracer Targeting Both Mutated
Epidermal Growth Factor Receptor and Anaplastic Lymphoma Kinase
por: Högnäsbacka, Antonia A., et al.
Publicado: (2023) -
PET imaging of P2X(7)R in the experimental autoimmune encephalomyelitis model of multiple sclerosis using [(11)C]SMW139
por: Beaino, Wissam, et al.
Publicado: (2020)